Hyaluronic acid filler with advanced crosslinking technology proves safe and effective for long-term facial volumization and wrinkle correction

Background The novel hyaluronic acid (HA) filler, utilizing a new technology, may offer long-lasting volumization and satisfactory correction. Objective This study assessed the efficacy and safety of HA with Cha-Heart Dispersion Technology (HA-CHDT) for treating facial volume loss, providing long-lasting volumization and satisfactory correction. Methods The study included 106 healthy subjects seeking volume restoration across various facial areas, excluding the lips and infraorbital regions. Facial condition before treatment was assessed using the 5-Point Facial Volume Loss Scale (FVLS). Efficacy was evaluated through physician and subject ratings of facial volume improvement using the FVLS and the Global Aesthetic Improvement Scale (GAIS), with assessments at baseline, day 14, 6 months, and 52 weeks. Results Overall, HA-CHDT improved facial volume in all 9 facial regions, as indicated by FVLS scores from baseline through the study. Statistically significant gradual correction relative to baseline persisted to 12 months only in the nasolabial folds, temples, chin, and jawline ( p < 0.05). Subject and physician-GAIS scores also showed improved volume correction up to 12 months. Both physician and subject GAIS scores improved significantly compared with baseline ( p < 0.05). However, small sample sizes ( n = 7–9) and the conservative Bonferroni correction limited pairwise comparisons for the forehead, glabella, nasal, and marionette areas. The treatment was generally well tolerated, with only minor adverse events. Patient satisfaction was high, with most subjects indicating they would return for future treatments and recommend it to friends. Conclusions HA-CHDT can be effective, well-tolerated, and a plausible option for treating moderate-to-severe facial volume loss.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-18
DOI
https://doi.org/10.3389/fmed.2026.1828302
Primary Topic
Facial Rejuvenation and Surgery Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hyaluronic acid filler with advanced crosslinking technology proves safe and effective for long-term facial volumization and wrinkle correction

Aydın Saray
1 links
Frontiers in Medicine
Facial Rejuvenation and Surgery Techniques
article

Hyaluronic acid filler with advanced crosslinking technology proves safe and effective for long-term facial volumization and wrinkle correction

Aydın Saray
article en

Abstract

Background The novel hyaluronic acid (HA) filler, utilizing a new technology, may offer long-lasting volumization and satisfactory correction. Objective This study assessed the efficacy and safety of HA with Cha-Heart Dispersion Technology (HA-CHDT) for treating facial volume loss, providing long-lasting volumization and satisfactory correction. Methods The study included 106 healthy subjects seeking volume restoration across various facial areas, excluding the lips and infraorbital regions. Facial condition before treatment was assessed using the 5-Point Facial Volume Loss Scale (FVLS). Efficacy was evaluated through physician and subject ratings of facial volume improvement using the FVLS and the Global Aesthetic Improvement Scale (GAIS), with assessments at baseline, day 14, 6 months, and 52 weeks. Results Overall, HA-CHDT improved facial volume in all 9 facial regions, as indicated by FVLS scores from baseline through the study. Statistically significant gradual correction relative to baseline persisted to 12 months only in the nasolabial folds, temples, chin, and jawline ( p < 0.05). Subject and physician-GAIS scores also showed improved volume correction up to 12 months. Both physician and subject GAIS scores improved significantly compared with baseline ( p < 0.05). However, small sample sizes ( n = 7–9) and the conservative Bonferroni correction limited pairwise comparisons for the forehead, glabella, nasal, and marionette areas. The treatment was generally well tolerated, with only minor adverse events. Patient satisfaction was high, with most subjects indicating they would return for future treatments and recommend it to friends. Conclusions HA-CHDT can be effective, well-tolerated, and a plausible option for treating moderate-to-severe facial volume loss.

Frontiers in MedicineVol. 13
Aesthetic Surgery Center (US)
Good health and well-being
Facial Rejuvenation and Surgery Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon